Bio-Gene Technology Limited

Further Funds Raised Under The Placement Bio-Gene’s Share Purchase Plan Commences

Bio-Gene Technology Limited (ASX: BGT, Bio-Gene or the Company), an agtech development company enabling the next generation of novel insecticides to address insecticide resistance, announced the launch of a placement and SPP on 1 September 2023. On 5 September 2023 Bio-Gene announced that it had received commitments to raise $1.4 million via a share placement to sophisticated and professional investors. Today the Company announces that it has received a further amount of $500,000 as part of the placement.

  • Total amount raised under the placement has increased to $1.9 million.
  • The Share Purchase Plan forms part of the capital raising initiative announced on 1 September 2023.
  • Eligible shareholders are offered shares under the SPP at the same price of $0.084 (8.4 cents) as was offered to sophisticated and professional investors, up to a maximum of $10,000 per eligible shareholder.
  • Funds for the production of FLAVOCIDE® active constituent and the conduct of key studies required for regulatory approval application in Australia.
The funds raised under the placement and the SPP will enable the production of FLAVOCIDE® active constituent and the conduct of key toxicology and other studies required for inclusion in the dossier of data to support an application for registration of FLAVOCIDE® active constituent in Australia.

Tim Grogan, Bio-Gene’s Managing Director and Chief Executive Officer, commented:

“The support of Bio-Gene’s shareholders is critically important in enabling the Company to move forward with the development and commercialisation of the FLAVOCIDE® active constituent. We are very pleased with the response to the placement from sophisticated and professional investors, and the SPP enables our Eligible Shareholders to participate in the Company’s current capital raising.”

Share Purchase Plan (SPP)

In order to allow existing Eligible Shareholders (defined below) to participate in the capital raising, the Company is offering to issue fully paid ordinary shares in the Company under a Share Purchase Plan (SPP) without disclosure to investors under Part 6D.2 of the Corporations Act 2001. Under the SPP, Eligible Shareholders will be able to purchase up to $10,000 worth of new fully paid ordinary shares in the Company, irrespective of the number of shares an Eligible Shareholder currently holds.

Eligible Shareholders are those shareholders whose registered address is in Australia as at 7.00 pm (AEST) on 31 August 2023 (Record Date). Shareholders with a registered address outside Australia at the Record Date will not be eligible to participate in the SPP. The closing date for the SPP is 5:00 pm (AEST) on 27 September 2023 (and if this date changes, an announcement will be made to ASX). Further details are included in the SPP Offer Booklet which is being dispatched to Eligible Shareholders and released to ASX.

Click here for the full ASX Release

This article includes content from Bio-Gene Technology Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.

The Conversation (0)
Nevada Organic Phosphate: Significant Milestone Reached as Final Murdock Mountain EA posted for Public Comment

Nevada Organic Phosphate: Significant Milestone Reached as Final Murdock Mountain EA posted for Public Comment

Nevada Organic Phosphate Inc. (CSE: NOP) ("NOP" or the "Company), a B.C. based exploration company focussed on Nevada's organic, sedimentary raw rock phosphate, is pleased to report that it has been advised by the U.S. Bureau of Land Management (BLM) that the final Murdock Mountain Environmental Assessment (EA) report was published for public comment on July 5, 2024. Posted along with the final EA, is the BLM's draft 'Finding of No Significant Impact' (FONSI).

The public consultation period will continue until August 4, 2024, at which time public comments will be addressed and any final changes to the Exploration Plan can be made. The BLM can then elect to issue to NOP its Exploration Permit which will allow NOP to plan its drill programme.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Wide Open Agriculture

WOA Proprietary Technology Successfully Adapted to Produce Pea & Faba Protein Isolates

Wide Open Agriculture Limited (ASX: WOA, "Wide Open Agriculture" or the "Company") is pleased to announce it has successfully developed functionally enhanced protein isolates from both pea and faba using our exclusive proprietary technology.

Keep reading...Show less
Wide Open Agriculture

Wide Open Agriculture

Keep reading...Show less
Wide Open Agriculture

Wide Open Ingredients

Investor Presentation | June 2024

Keep reading...Show less

Innovations in the Plant-based Protein Market Every Investor Should Know

With the global population set to reach 10 billion by 2050, the need for more sustainable sources of protein is becoming increasingly vital — and also more challenging to fulfill. This challenge is creating new opportunities for innovation in developing healthier alternatives to meat and driving revenue opportunities through the plant-based protein value chain.

Investors closely watching this space would benefit from a deeper understanding of the current innovations and opportunities in the plant-based protein market.

Keep reading...Show less

Latest Press Releases

Related News